346
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 103-113 | Received 23 Aug 2020, Accepted 06 Jan 2021, Published online: 02 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amir Hossein Aalami, Hossein Abdeahad, Ali Shoghi, Mohammad Mesgari, Amir Amirabadi & Amirhossein Sahebkar. (2022) Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis. Expert Review of Molecular Diagnostics 22:2, pages 201-211.
Read now

Articles from other publishers (12)

Amir Hossein Aalami, Farnoosh Aalami & Amirhossein Sahebkar. (2023) Gastric Cancer and Circulating microRNAs: An Updated Systematic Review and Diagnostic Meta-Analysis. Current Medicinal Chemistry 30:33, pages 3798-3814.
Crossref
Jiaqi Qiu, Zhenjie Fu, Hang Wen & Yitao Chen. (2023) Identification of the novel prognostic biomarker SERPINH1 reveals its relationship with immunology in gastric cancer. Oncologie 0:0.
Crossref
Jakub Wnuk, Joanna Katarzyna Strzelczyk & Iwona Gisterek. (2023) Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature. International Journal of Molecular Sciences 24:6, pages 5113.
Crossref
I-Ping Yang, Kwan-Ling Yip, Yu-Tang Chang, Yen-Cheng Chen, Ching-Wen Huang, Hsiang-Lin Tsai, Yung-Sung Yeh & Jaw-Yuan Wang. (2023) MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review. Cancers 15:5, pages 1358.
Crossref
Amir Hossein Aalami, Hossein Abdeahad, Farnoosh Aalami & Amir Amirabadi. (2023) Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer. Urologic Oncology: Seminars and Original Investigations 41:1, pages 52.e1-52.e10.
Crossref
Amir Hossein Aalami, Mohammadsaleh Hoseinzadeh, Parsa Hosseini Manesh, Ali Jiryai Sharahi & Ehsan Kargar Aliabadi. (2022) Carcinogenic effects of heavy metals by inducing dysregulation of microRNAs: A review. Molecular Biology Reports 49:12, pages 12227-12238.
Crossref
Mahdi Qasemi Rad, Vahid Pouresmaeil, Fatemeh Hosseini Mojahed, Amir Amirabadi & Amir Hossein Aalami. (2022) Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer. Molecular Biology Reports 49:7, pages 6975-6985.
Crossref
Maryam Koopaie, Sajad Kolahdooz, Mahnaz Fatahzadeh & Soheila Manifar. (2022) Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta‐analysis. Cancer Medicine 11:13, pages 2644-2661.
Crossref
Ana E. Jenike & Marc K. Halushka. (2021) miR-21: a non‐specific biomarker of all maladies. Biomarker Research 9:1.
Crossref
M.M. Xuan Yang & M.M. Wen Zhang. (2021) A commentary on “Integrative systematic review meta-analysis and bioinformatics identifies MicroRNA-21 and its target genes as biomarkers for colorectal adenocarcinoma” (Int J Surg 2020; 73:113–122). International Journal of Surgery 92, pages 106025.
Crossref
Ha Thi Nguyen, Salah Eddine Oussama Kacimi, Truc Ly Nguyen, Kamrul Hassan Suman, Roselyn Lemus-Martin, Humaira Saleem & Duy Ngoc Do. (2021) MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology 10:5, pages 417.
Crossref
Amir Hossein Aalami, Hossein Abdeahad, Mohammad Mesgari, Thozhukat Sathyapalan & Amirhossein Sahebkar. (2021) Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis. BioMed Research International 2021, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.